Panomics operates in the biotechnology and diagnostics sector, focusing on developing advanced diagnostic tests and solutions. The company serves healthcare providers, medical laboratories, and research institutions, primarily in Germany and Austria. Panomics' business model revolves around the creation and distribution of diagnostic tests, including those for COVID-19, which help in early detection and prevention of diseases. Revenue is generated through the sale of these diagnostic tests and related services. The company partners with regulatory authorities like the FDA to ensure the availability and efficacy of their products. By enabling swift response to medical challenges, Panomics aims to improve patient outcomes and public health.

Keywords: biotechnology, diagnostics, healthcare, medical laboratories, COVID-19 tests, disease prevention, regulatory compliance, patient care, Germany, Austria.